Bausch Health Companies | VRX - Ebitda

Stock Price
7.87
Daily Change
0.10 1.22%
Monthly
-22.97%
Yearly
-25.38%
Q1 Forecast
7.62

Bausch Health Companies reported $986M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Amgen USD 5.91B 2.31B Sep/2025
ANI Pharmaceuticals USD 59.6M 5.52M Sep/2025
Aurora Cannabis CAD 15.37M 26.8M Sep/2025
Bausch Health Companies USD 986M 74M Sep/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Canopy Growth CAD 16.62M 38.45M Sep/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Danaher USD 2.13B 252M Dec/2025
Drreddys Laboratories INR 21.59B 1.49B Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
Novo Nordisk DKK 31.44B 6.84B Sep/2025
Pacira USD 49.36M 4.96M Sep/2025
Perrigo USD 258.8M 37.3M Sep/2025
Prestige Brands USD 86.83M 7.19M Sep/2025
Supernus Pharmaceuticals USD 41.9M 432K Sep/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025
Zoetis USD 1.04B 87M Sep/2025